Cargando…
Modulation of androgen receptor DNA binding activity through direct interaction with the ETS transcription factor ERG
The androgen receptor (AR) is a type I nuclear hormone receptor and the primary drug target in prostate cancer due to its role as a lineage survival factor in prostate luminal epithelium. In prostate cancer, the AR cistrome is reprogrammed relative to normal prostate epithelium and particularly in c...
Autores principales: | Wasmuth, Elizabeth V., Hoover, Elizabeth A., Antar, Albert, Klinge, Sebastian, Chen, Yu, Sawyers, Charles L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165421/ https://www.ncbi.nlm.nih.gov/pubmed/32220959 http://dx.doi.org/10.1073/pnas.1922159117 |
Ejemplares similares
-
Allosteric interactions prime androgen receptor dimerization and activation
por: Wasmuth, Elizabeth V., et al.
Publicado: (2022) -
ERG signaling in prostate cancer is driven through PRMT5-dependent methylation of the Androgen Receptor
por: Mounir, Zineb, et al.
Publicado: (2016) -
SAT634 The Androgen Receptor Does Not Directly Regulate The Transcription Of DNA Damage Response Genes
por: Hasterok, Sylwia, et al.
Publicado: (2023) -
GREB1 amplifies androgen receptor output in human prostate cancer and contributes to antiandrogen resistance
por: Lee, Eugine, et al.
Publicado: (2019) -
Discovery and characterization of small molecules targeting the DNA-binding ETS domain of ERG in prostate cancer
por: Butler, Miriam S., et al.
Publicado: (2017)